vimarsana.com
Home
Live Updates
GSK to present new data from the B-Clear phase IIb trial for bepirovirsen in chronic hepatitis B at the International Liver Congress 2022 : comparemela.com
GSK to present new data from the B-Clear phase IIb trial for bepirovirsen in chronic hepatitis B at the International Liver Congress 2022
GSK plc will present 12 abstracts at the European Association for the Study of the Liver’s International Liver Congress 2022, taking place on June 22-26 in London.
Related Keywords
United Kingdom ,
London ,
City Of ,
Vera Gielen ,
Jennifer Cremer ,
Fung Yuen ,
Fernando Carren ,
Helen Smith ,
Ahmed Nader ,
Chris Corsico ,
Martin Leivers ,
James Fettiplace ,
Drug Administration ,
European Medicines Agency ,
International Liver Congress ,
London United Kingdom ,
European Association ,
Late Breaker ,
Targeted Literature Review ,
Congress ,
Disease ,
Medical Specialties ,
Nasdaq ,
Pharmaceuticals ,
Bile Acid ,
Cholestasis ,
Cholestatic Pruritus ,
Clinical Medicine ,
Hbsag ,
Hepatitis ,
Hepatology ,
Liver Cancer ,
Liver Disease ,
Liver Transplantation ,
Primary Biliary Cholangitis ,
comparemela.com © 2020. All Rights Reserved.